MedAdvisor Limited (ASX:MDR) Provides Strategic Review Update
MedAdvisor Limited (ASX:MDR) announces a strategic review update, detailing a potential $35 million sale of its ANZ business division to a major software firm.
Category: ASX-MDR
MedAdvisor Limited
MedAdvisor Limited (ASX:MDR) Implements Trading Halt Pending Acquisition Proposal
MedAdvisor Limited (ASX:MDR) places trading halt pending strategic acquisition proposal of ANZ business division.
MedAdvisor Limited (ASX:MDR) Receives LOI for ANZ Division Acquisition
MedAdvisor Limited (ASX:MDR) receives a non-binding LOI to sell its ANZ division, reflecting a higher value than current share price.
MedAdvisor Limited (ASX:MDR) Releases 3Q FY25 Financial Update
MedAdvisor Limited (ASX:MDR) reports a significant decrease in 3Q FY25 revenue, announces cost-cutting measures and strategic initiatives.